Related Experiment Video
Updated: Oct 18, 2026

Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography
Published on: December 27, 2024
The biologic basis for the use of retinoids in cancer prevention and treatment
1Department of Thoracic/Head and Neck Medical Oncology, University of Texas-M.D. Anderson Cancer Center, Houston 77030, USA.
Abstract:
Retinoids (vitamin A and related molecules) are biologic agents that have demonstrated, in preclinical and clinical models, potent activity in the prevention and treatment of a variety of malignancies. Presented in this article is a review of recent clinical studies and correlative laboratory findings that advance our understanding of the biologic basis for the use of retinoids in cancer prevention and treatment.
Insights
Retinoids, vitamin A derivatives, show significant promise in preventing and treating various cancers. Recent studies explore the biological mechanisms behind their anti-cancer effects, supporting their therapeutic potential.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Retinoids, vitamin A derivatives, are recognized for their potent anti-cancer properties.
- Preclinical and clinical evidence supports retinoid activity in malignancy prevention and treatment.
Purpose of the Study:
- To review recent clinical studies on retinoids in cancer.
- To explore the biologic basis for retinoid use in cancer prevention and treatment.
Main Methods:
- Review of clinical studies.
- Analysis of correlative laboratory findings.
Main Results:
- Retinoids demonstrate potent activity against various malignancies.
- Advancement in understanding the biological mechanisms of retinoids in cancer.
Conclusions:
- Retinoids are promising biologic agents for cancer prevention and treatment.
- Further research into retinoid mechanisms can optimize cancer therapy.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer Prevention
Some...
Cancer Prevention
Some...
Inhibition of Cdk Activity
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
